UNCF, Bristol Myers Squibb Announce Second Cohort of the Ernest E. Just Postgraduate Fellowship and Extension of Partnership Through 2026 Biotech Investing
Bristol Myers Squibb to Host Virtual Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia® in Ulcerative Colitis at UEG Week 2020 Biotech Investing
Public coverage of AbbVie's SKYRIZI® for the treatment of Moderate to Severe Plaque Psoriasis is now available across additional jurisdictions Biotech Investing
Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020 Biotech Investing
Algernon Announces Enrollment of 100 Patients in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
Health Canada Approves REBLOZYL® , New Class of Treatment for Adult Patients Living with Beta Thalassemia Biotech Investing
Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs Biotech Investing
Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using its DehydraTECH technology in Delivering Antiviral Drugs Biotech Investing
